NEW YORK, Dec. 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
European Markets for Orthopedic Biomaterials
http://www.reportlinker.com/p01907831/European-Markets-for-Orthopedic-Biomaterials.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomaterial
The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment.
The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantation (ACI). As the market continued to recover from the economic crisis, slow growth was often seen across different regions. The ACI market underwent drastic changes in 2012 due to modifications in the European Medicines Agency (EMA) regulations.
While autografts were still commonly used in 2012, easy accessibility and price declines have made bone graft substitute products an attractive option. Surgeons and patients alike have become increasingly interested in minimally invasive procedures, which greatly decrease the pain associated with bone graft procedures.
Scope:
This report pertains to a forecast period of 10 years (2009 – 2019) for:
Austria
Belgium
Denmark
Finland
France
Germany
Italy
Luxembourg
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
U.K.
Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment & Country
Trend Analysis by Segment & Country
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring
Main Segments Included:
Bone Graft Substitute Market
Allograft Bone Graft Substitute Market
Synthetic Bone Graft Substitute Market
Demineralized Bone Matrix Bone Graft Substitute Market
Hyaluronic Acid Viscosupplementation Market
Bone Morphogenetic Protein Growth Factor Market
Autologous Chondrocyte Implantation Market
Sub-Segments Included:
Allograft Cervical Spine Market
Allograft Thoracolumbar Spine Market
Allograft Trauma and Reconstruction Market
Allograft Craniomaxillofacial Market
Synthetic Cervical Spine Market
Synthetic Thoracolumbar Spine Market
Synthetic Trauma and Reconstruction Market
Synthetic Craniomaxillofacial Market
Cervical Spine Demineralized Bone Matrix Market
Thoracolumbar Spine Demineralized Bone Matrix Market
Trauma and Reconstruction Demineralized Bone Matrix Market
Craniomaxillofacial Demineralized Bone Matrix Market
Companies Included:
DePuy SynthesOlympus
Zimmer
Wright Medical
Smith & Nephew
RottaPharm
Fidia
Genzyme
Medtronic
TRB Chemedica
Laboratoire Genevrier
Stryker
RTI Biologics
Biomet
Croma-Pharma
TiGenix
Fin-Ceramica
Tedec-Meiji
Seikagaku
Others include:
Anika, Bioiberica, Biocomposites Ltd, Biomatlante, Biomet, Curasan, Documedica, Exactech, Ferring, Geistlich, Integra Biologics, Kuros, LCA Pharmaceuticals, Ortotech, Plasmaconcept AG, Recordati, Scient'x-Alphatec Spine, Stella Pharmaceuticals.
TABLE OF CONTENTS I
LIST OF FIGURES V
LIST OF CHARTS XV
EXECUTIVE SUMMARY 1
1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET 1
1.2 BONE GRAFT SUBSTITUTE MARKET 2
1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET 3
1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET 4
1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET 5
1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 6
1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET 7
1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 8
1.9 COMPETITIVE ANALYSIS 9
RESEARCH METHODOLOGY 11
2.1 RESEARCH SCOPE 11
2.2 IDATA'S 9-STEP METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 13
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 18
Step 8: Final Review and Market Release 19
Step 9: Customer Feedback and Market Monitoring 20
EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET 21
3.1 INTRODUCTION 21
3.1.1 Products 22
3.1.1.1 Growth Factors 22
3.1.1.2 Bone Graft Substitutes 22
3.1.1.3 Hyaluronic Acid Viscosupplementation 22
3.1.1.4 Autologous Chondrocyte Implantation 22
3.2 CURRENCY EXCHANGE RATE 23
3.3MARKET OVERVIEW 24
3.4 TREND ANALYSIS 29
3.5 DRIVERS AND LIMITERS 32
3.5.1 Market Drivers 32
3.5.2 Market Limiters 32
3.6 COMPETITIVE ANALYSIS 34
3.7MARKET CONCENTRATION 38
3.8MERGERS AND ACQUISITIONS 40
COUNTRY PROFILES 43
4.1 INTRODUCTION 43
4.1.1 Population 43
4.1.2 GDP per Capita 43
4.1.3 Procedures 43
4.1.4 Price Index 44
4.2 GERMANY 45
4.3 FRANCE 46
4.4 UNITED KINGDOM 47
4.5 SPAIN 48
4.6 ITALY 49
4.7 BENELUX 50
4.8 SCANDINAVIA 51
4.9 SWITZERLAND 52
4.10 AUSTRIA 53
4.11 Portugal 54
BONE GRAFT SUBSTITUTE MARKET 55
5.1 INTRODUCTION 55
5.1.1 Volumes Represented per Procedure 57
5.2MARKET OVERVIEW 58
5.2.1 Bone Graft Substitute Market by Indication 58
5.2.2 Bone Graft Substitute Market by Segment 62
5.3MARKET ANALYSIS AND FORECAST 66
5.3.1 Total Bone Graft Substitute Market 66
5.3.2 Total Allograft Market 74
5.3.2.1 Total Allograft Spine Market 82
5.3.2.1.1 Allograft Cervical Spine Market 90
5.3.2.1.2 Allograft Thoracolumbar Spine Market 98
5.3.2.1.3 Allograft Trauma and Reconstruction Market 106
5.3.2.2 Allograft Craniomaxillofacial Market 114
5.3.3 Total Synthetic Market 122
5.3.3.1 Total Synthetic Spine Market 130
5.3.3.2 Synthetic Cervical Spine Market 138
5.3.3.3 Synthetic Thoracolumbar Spine Market 146
5.3.3.4 Synthetic Trauma and Reconstruction Market 154
5.3.3.5 Synthetic Craniomaxillofacial Market 162
5.3.4 Total Demineralized Bone Matrix Market 170
5.3.4.1 Total Spine Demineralized Bone Matrix Market 178
5.3.4.2 Cervical Spine Demineralized Bone Matrix Market 186
5.3.4.3 Thoracolumbar Spine Demineralized Bone Matrix Market 194
5.3.4.4 Trauma and Reconstruction Demineralized Bone Matrix Market 202
5.3.4.5 Craniomaxillofacial Demineralized Bone Matrix Market 210
5.4 DRIVERS AND LIMITERS 218
5.4.1 Market Drivers 218
5.4.2 Market Limiters 219
5.5 COMPETITIVE ANALYSIS 221
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 225
6.1 INTRODUCTION 225
6.2MARKET OVERVIEW 227
6.3MARKET ANALYSIS AND FORECAST 231
6.3.1 Total Hyaluronic Acid Viscosupplementation Market 231
6.3.2 Single-Injection Market 239
6.3.2.1 Three-Injection Market 247
6.3.2.2 Five-Injection Market 255
6.4 DRIVERS AND LIMITERS 263
6.4.1 Market Drivers 263
6.4.2 Market Limiters 264
6.5 COMPETITIVE ANALYSIS 266
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET 271
7.1 INTRODUCTION 271
7.2MARKET ANALYSIS AND FORECAST 272
7.3MARKET DRIVERS AND LIMITERS 279
7.3.1 Market Drivers 279
7.3.2 Market Limiters 279
7.4 COMPETITIVE ANALYSIS 281
AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 285
8.1 INTRODUCTION 285
8.1.1 Regulations and Legislation 286
8.2MARKET ANALYSIS AND FORECAST 287
8.3 DRIVERS AND LIMITERS 294
8.3.1 Market Drivers 294
8.3.2 Market Limiters 294
8.4 COMPETITIVE ANALYSIS 296
ABBREVIATIONS 299
To order this report: European Markets for Orthopedic Biomaterials
http://www.reportlinker.com/p01907831/European-Markets-for-Orthopedic-Biomaterials.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomaterial
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article